(346 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Late onset T2 asthma – a case study
-
Danger signs
-
Updates in [severe] asthma in adults
-
Primary care in CRDs during COVID
-
Exercise: induced asthma and rhinitis
-
Bronchiectasis and severe asthma
-
Update on drug allergy
-
Precision Medicine and AIT
-
E-cigarettes: mechanistic link to lung injury
-
Electronic Health in Severe Asthma
-
An update on food allergy
-
Elderly asthma
-
Precision medicine in immunodeficiency
-
Severe Asthma and COVID-19
-
Elevated tryptase – Now what?
-
Hologenome and obesity
-
How do allergens sensitize?
-
Current status on prophylaxis in HAE
-
Novel cell based assays in allergy diagnostics
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Food allergy - the beginners guide
-
Launch of the Biological guidelines
-
Difficult to control asthma in adults
-
Is IgA a piece of the EoE puzzle?
-
Risk assessment and active management of food allergy
-
Autoimmunity in atopic diseases
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
Collective advocacy for action on CRDs
-
Food industry perspective
-
Targeted approaches for asthma
-
Asma e alergia em pandemia
-
Focus on Patient. Personalised therapy for severe asthma
-
AAAAI Practice Parameters
-
Plans of GARD in terms of surveillance after COVID
-
Adherence: A challenge for Immunotherapy
-
New perspectives for anaphylaxis
-
Preparing a grant: Dos and Don'ts
-
Difficult to control asthma in children
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Vaccines- Is this the tool to end the pandemic?
-
Viral infection and asthma
-
Living with food allergy
-
Lung function testing
-
Bronchial allergen challenge in research
-
Bronchial allergen challenge in the clinic
-
GINA Guidelines Update
-
Innate trained immunity: An evolutionary perspective
-
Immunological basis of food aversion
-
Current and future perspectives
-
When hives are not chronic urticaria
-
Predicting adverse reactions to biologicals
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Novel pharamacological targets
-
AI models
-
Phenotypes and Endotypes
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Immune response to Corona virus infection
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Measles infection causes immune amnesia
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Can we prevent the development of food allergy?
-
Urban green spaces - The exposure and allergenicity index
-
Inflammatory biomarkers
-
Delabelling adults
-
Cellular tests for the diagnosing and monitoring of allergy
-
Hypersensitivity to antiepileptic drugs
-
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Microbiota in immune-based therapies
-
AIT, Biologicals and Covid vaccination
-
Differential diagnosis
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Novel insight into development of allergic diseases
-
Management of adverse reactions to biologics
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
Asma e alergia em Angola
-
Exercise-induced urticaria and anaphylaxis
-
The basics of severe asthma - biomarkers
-
The brain, nose, immune axis
-
Desensitization in chemotherapy and biologics
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Tackling anaphylaxis
-
Therapies for multiple-tree nut allergies
-
How to evaluate lung function? Hands-on plus lecture
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
Early biomarkers for severe drug hypersensitivity reactions
-
Skin care from birth for allergy prevention: results today
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
-
Telemedicine and Tele-health
-
Novel approaches of allergen immunotherapy
-
Update of the WAO anaphylaxis guidance
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Eosinophilic fasciitis, an unusual presentation
-
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
-
How to improve outcomes
-
Diagnosis of insect venom allergy: back to basics
-
Immunotherapy in severe asthma (AIT)
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
An update on prevention of allergic diseases
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
Chronic rhinosinusitis with nasal polyps
-
What’s different about the adolescent brain?
-
Asthma: phenotypes to endotypes
-
Neuroimmunology and allergy
-
Evidence of immunotherapy on allergy prevention?
-
Should we do patch testing in children with eczema?
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Role Viral reactivations
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
What is the immunological basis for new biologicals?
-
Mental health needs and access to care among patients with food allergy
-
Gut microbiome - based therapeutic approaches
-
Do adrenaline auto-injectors save lives?
-
Epithelial cell barrier and allergic diseases
-
Recognizing immediate reactions in contact dermatitis
-
Big changes in asthma treatment : GINA 2019
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Unusual presentations of contact dermatitis
-
BAT in clinical practice. Is it possible?
-
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Impact of climate change on the immune system
-
Early life wheeze - risk factors for asthma in school age
-
Treating allergic patients during the COVID-19 pandemic
-
New insights in urticaria mechanisms
-
B cell tolerance: an essential mechanism for allergen immunotherapy in house dust mite allergy
-
Allergen immunotherapy for food allergy
-
Is anaphylaxis really rare in children?
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Biotin interference can cause false-negative IgE test results in patients with anaphylaxis
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
The underlying immunology of pruritus
-
Social media and Allergies: how can we support our patients?
-
Role of antigen-presenting cells in tolerance and allergy
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
How can we improve the quality of life of patients with severe food allergy?
-
Outcome measures for adult’s vs children in the clinic during allergen immunotherapy
-
Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
-
Global impact of the COVID-19 on the environment
-
Impact of climate change on asthma exacerbations
-
AIT in the pediatric population
-
Mesenchymal stem cells ameliorate long term pulmonary complications induced by sulfur mustard
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
Can the birch pollen be more aggressive in the polluted environments?
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Impacting quality of life with PALFORZIA
-
Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Assessment of adherence to treatment using mHealth
-
Nasal allergen challenge
-
Challenges on the implementation of early introduction of allergenic foods
-
Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy
-
Molecular and structural considerations for aerosolization of food allergens
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Are drug provocation tests required before decision to desensitize?
-
Psychological support to peanut allergic children and their families
-
It looks like urticaria – but is it?
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Fecal transplantation: a safe and efficient treatment option for gut dysbiosis? (Pro & Con Session: Con)
-
Fecal transplantation: a safe and efficient treatment option for gut dysbiosis? (Pro & Con Session: Pro)
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
The clinical clues and pitfalls in contact dermatitis
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
What do we learn from subgroup analyses in phase-III trials?
-
Covid-19 in "Allergy" journal
-
Tezepelumab (anti-TSLP) in asthma
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Precision medicine and biomarkers of atopic dermatitis
-
Impact of food allergy on household expenditures among Manitoba families
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Big data and cluster analysis: a real life perspective
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Air pollution and allergy: call for action!
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Characterization of the immunological properties of different β-glucans on myeloid dendritic cells
-
Implementing component resolved diagnostics in allergy diagnosis
-
Big Data Analysis: MetabolomicsView Presentation
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
Ligelizumab (anti-IgE) in chronic spontaneous urticaria
-
A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC)
-
The dilemma of food allergy additives
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Allergy to Kale
-
A patient with an acute reaction: recognize, document and treat
-
Environment and Immunology StandUp TalksSpeakers ...
-
Food allergy: new allergens on the block
-
Pathogenic Th cell population disease induction model: - From the recruitment of eosinophils to the induction of fibrosis
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
Quality of life in mastocytosis scale (QLMS) - the construction of the disease-specific questionnaire
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Hand eczema during the COVID-19 pandemic
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Covid 19 and air pollution: is there a relationship?
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
Over-the-counter allergy prevention weaning products
-
How to select and follow a biological for asthma and CRSwNP
-
Anti IL4/13 and IL33/TSLP
-
Occupational respiratory allergy in food processing industries
-
The engineering-medicine interface
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
Integrated systems biology strategies for diagnostics and immune monitoring in allergy
-
Value of c-kit mutations in the skin, peripheral blood and bone marrow in pediatric mastocytosis. What does it tell us?
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
Multiple myeloma exosomes suppress natural killer cells: Modification by omega-3 fatty acids
-
Hypereosinophilic syndromes and autoimmunity
-
Route of exposure determines the immune response to food allergens
-
Development of a childhood asthma prediction model using machine learning approaches
-
Environmental epigenomics of allergy
-
Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
How does Type 2 mucosal inflammation influence susceptibility to SARS-CoV-2?
-
Influence of antigen density and TLR ligands on efficacy of a VLP-based vaccine against Peanut Allergy: mechanistic insights
-
How to use social media in your professional practice: the clinician perspective
-
Human and computational models of immune mediated inflammatory skin disease: challenges, insights and perspectives
-
Structural biology of food allergens and cross reactivity
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Con)
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Pro)
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
Vaccines for older adults: benefits and limitations
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Practical Course on Big data analysis: transcriptomics, metabolomics, CyTOF and flow cytometryView Presentation
-
Tree nut allergy: path from national to global data
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Immune responses in desentitization and tolerance
-
Drug provocation test in non-immediate beta-lactam hypersensitivity workup: One-day vs prolonged protocol in pediatric patients
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
Reduction in rescue medication use in patients treated with the 300IR house dust mite slit table
-
Prevention of food allergy: where are we now?
-
Basophil activation test results change in birch pollen sensitized patients during first season of immunotherapy
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
The role of the extended provocation test: Diagnosing non-immediate beta-lactam hypersensitivity in paediatrics
-
Understanding parent preferences for paediatric allergy services
-
Lesson learned from the pathogenesis of SARS-COV2
-
Insight from translational research on oral tolerance induction through breast milk
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Molecular allergology in daily clinical practice
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Mechanisms of non IgE mediated food allergy
-
Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
-
Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study
-
Impaired olfaction: diagnostics and its role in diseases
-
Oral food challenges thresholds for clinical reactions
-
Non-T2 directed biologicals
-
The role of infection in chronic spontaneous urticaria
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project
-
MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study
-
Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis
-
Moisturisers for the primary prevention of food allergy
-
Phenotypes and endotypes of occupational allergy
-
Potential usefulness of in-vitro tools for identifying aeroallergens sensitization in suspected local allergic rhinitis
-
Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
Show more Event Resources (280)Show Less-
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityAbstract Immediate and nonimmediate hypersensitivity reactions to iodinated contrast medi...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animalsAbstract Adverse reactions to insects occur in both human and veterinary patients. System...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic studyAbstract Research data derived from observational studies are accumulating quickly in the...
Show more Position Papers (36)Show Less-
-
Reconsider the art of AITWelcome and introduction Pati...
-
Advances in eosinophilic diseases
-
To eat or not to eat: that is the questionNutrition and gut health for prevention of food allergy ...
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Clinical Cases in discussion: 3 patients, 3 experts & 1 solutionPablo Rodríguez Del Río, Torsten Zuberbier, Fulvio Braido, Mélisande Rouger
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
Mite – the “diva” in AIT trialsWelcome and introduction Fill...
-
Peanut allergy and investigational DBV712: an updateIntroduction Antonella Muraro ...
-
Meet the experts on AIT in Food AllergyWelcome & Introduction Hans Van Schij...
-
Allergic patient: The Real WorldIntroduction European patient...
-
Pioneering a new age – fighting allergic disease on all fronts!Introduction video Introducti...
-
Chronic spontaneous urticaria: defining the pathway to successful managementWelcome and Introduction Marcus Maurer ...
-
Patients’ perspective : a must have for the future of Allergen ImmunotherapyIntroduction What can a patie...
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Furthering AIT`s promises with precision medicineOpening remarks G.Walter Canonica ...
-
How can we improve the approach to treating chronic urticaria in children?Introduction Montserrat Alvaro Lozano ...
-
Mometasone furoate/ olopatadine: the value of novelty patient-centred careIntroduction and Patient Testimony ...
-
IgE in asthma and nasal polyposis: your questions answered
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Re-thinking lung function testing in young children
-
The Link between Early Diet and Food AllergyIntroduction Liam O’Mahony ...
-
Improving patients’ journeys in food allergyWelcome and introduction Alexandra Santos ...
Show more Sponsored Symposia (20)Show Less-
-
Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemicSputum induction (SI) is the gold standard approach to the non‐invasive study of airway ...
-
COVID-19 Pandemic and allergen immunotherapy - an EAACI surveyAs in many fields of medical care, the coronavirus disease 2019 (COVID‐19) resulted in a...
-
Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and ItalyThis is a binational (Italian – Chinese) multicenter prospective study to assess cutaneo...
-
Is there a role for childhood vaccination against COVID-19?Tremendous efforts are undertaken to quickly develop COVID‐19 vaccines that protect vuln...
Show more Covid-19 (2)Show Less-